The company has played a prominent role in administering third doses to the immunocompromised and is prepared to provide booster shots from other manufacturers, as well as expand vaccine eligibility to ages 5-11, as soon as authorized to do so by public health agencies.Ĭlick here for our full COVID vaccination guide.A critical flu season is upon us.
Related: State vaccination coordinator discusses booster shot rollout for the CommonwealthĬVS Health has administered more than 34 million COVID-19 vaccines and 32 million COVID-19 tests across the country to date. Per CDC guidance, patients will be asked to self-attest to their eligibility as defined by the eligibility guidelines in order to help reduce barriers to access for these select populations. When scheduling an appointment on CVS.com, patients will be asked to provide the manufacturer and date of their last COVID-19 vaccine and will be able to schedule an appointment for a Pfizer-BioNTech booster dose if they have had two previous doses with the same vaccine at least six months prior.
#Cvs pharmacy covid vaccine voucher series
“We also continue to make it as convenient as possible for the unvaccinated to receive their first doses.”Īnyone who is interested in receiving the Pfizer-BioNTech COVID-19 booster or their initial vaccine series is strongly encouraged to make an appointment at CVS.com or to make sure they are able to access the correct vaccine at a convenient time and location.Ĭurrently, each participating CVS Pharmacy and MinuteClinic location is offering either the Pfizer-BioNTech, Moderna or Johnson & Johnson (Janssen) vaccine, but not all three. Brennan, M.D., MPH, executive vice president and chief medical officer of CVS Health. “We have the experience and the infrastructure to play a leading role in administering booster shots to eligible populations,” said Troyen A. People who initially received the Moderna or Johnson & Johnson (Janssen) COVID-19 vaccine are not eligible for a booster at this time, per guidance from the public health agencies. People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.People 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risk.
0 kommentar(er)
